Excelsior Biopharma Inc. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was TWD 362.731 million compared to TWD 418.690 million a year ago. Operating income was TWD 20.277 million compared to TWD 70.662 million a year ago. Net income was TWD 14.806 million compared to TWD 57.452 million a year ago. Basic earnings per share was TWD 0.32 compared to TWD 1.23 a year ago. For the nine months, sales was TWD 1,116.387 million compared to TWD 1,267.908 million a year ago. Operating income was TWD 62.370 million compared to TWD 212.451 million a year ago. Net income was TWD 47.220 million compared to TWD 163.218 million a year ago. Basic earnings per share was TWD 1.01 compared to TWD 3.5 a year ago. Diluted earnings per share was TWD 1.01 compared to TWD 3.48 a year ago.